Tissue Regenix Group plc (LON:TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL) and bone (BioRinse). It has a
Cizzle Biotechnology plc (LON:CIZ), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for the early detection of different forms of
Cizzle Biotechnology plc (LON:CIZ), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for the early detection of different forms of
Appreciate Group plc (LON:APP) The FY’22 results beat market expectations and saw strong digital growth, as well as a return to more normal redemption patterns. Unsurprisingly, the shares have reacted
Fidelity Asian Values plc (LON:FAS) performance is driven by stock selection, and that should never be overlooked. However, being in appealing markets gives favourable tailwinds, and, in this note, we
International Biotechnology Trust plc (LON:IBT) was established in 1994 to provide institutional and retail investors with the opportunity to participate in global biotechnology and life science companies, from venture-stage development
ICG Enterprise Trust plc (LON:ICGT) reported another strong year, with an NAV per share total return of 24.4%, its 13th consecutive year of double-digit NAV growth. It materially outperformed the
With Bank North having obtained its banking licence and progressing through its mobilisation period, this report updates investors on its rapid lending rollout – currently running better than plan in
In previous notes, we have repeatedly outlined why we believe Real Estate Credit Investments Ltd (LON:RECI) shows resilience against inflation, interest rate increases and inflation risk (inter alia, see Experience
The International Stock Exchange (TISE) had a very strong 2021: revenues were up 19% and profit before tax was up 29%, driven by an increase in listings. These figures were
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
